These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34531850)

  • 1. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
    Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
    Front Immunol; 2021; 12():661323. PubMed ID: 34531850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions.
    Dinarello A; Mills TS; Tengesdal IW; Powers NE; Azam T; Dinarello CA
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
    Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer.
    Zhang Z; Chen Y; Pan X; Li P; Ren Z; Wang X; Chen Y; Shen S; Wang T; Lin A
    Cell Commun Signal; 2024 Aug; 22(1):408. PubMed ID: 39164774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
    Theivanthiran B; Evans KS; DeVito NC; Plebanek M; Sturdivant M; Wachsmuth LP; Salama AK; Kang Y; Hsu D; Balko JM; Johnson DB; Starr M; Nixon AB; Holtzhausen A; Hanks BA
    J Clin Invest; 2020 May; 130(5):2570-2586. PubMed ID: 32017708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells.
    Lee BR; Kwon BE; Hong EH; Shim A; Song JH; Kim HM; Chang SY; Kim YJ; Kweon MN; Youn JI; Ko HJ
    Cancer Lett; 2016 Oct; 381(1):156-64. PubMed ID: 27431309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
    Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
    Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.
    Giammona A; De Vellis C; Crivaro E; Maresca L; Amoriello R; Ricci F; Anichini G; Pietrobono S; Pease DR; Fernandez-Zapico ME; Ballerini C; Stecca B
    J Exp Clin Cancer Res; 2024 Aug; 43(1):214. PubMed ID: 39090759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host.
    Song G; Zhang Y; Tian J; Ma J; Yin K; Xu H; Wang S
    Front Immunol; 2021; 12():649020. PubMed ID: 33717204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
    Zhang Z; Huang X; Wang E; Huang Y; Yang R
    J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway.
    Zhu Y; Zhou L; Mo L; Hong C; Pan L; Lin J; Qi Y; Tan S; Qian M; Hu T; Zhao Y; Qiu H; Lin P; Ma X; Yang Q
    J Immunol; 2024 Jul; 213(2):170-186. PubMed ID: 38819229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling.
    Zuurbier CJ; Jong WM; Eerbeek O; Koeman A; Pulskens WP; Butter LM; Leemans JC; Hollmann MW
    PLoS One; 2012; 7(7):e40643. PubMed ID: 22848390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment.
    Dumont A; de Rosny C; Kieu TL; Perrey S; Berger H; Fluckiger A; Muller T; Pais de Barros JP; Pichon L; Hichami A; Thomas C; Rébé C; Ghiringhelli F; Rialland M
    Cell Death Dis; 2019 Jun; 10(7):485. PubMed ID: 31217433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
    Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
    Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.